Study Finds Statin Users 3 Times Less Likely To Develop Prostate Cancer
Prostate cancer is the second leading cause of cancer death in the
world. New research points to a group of cholesterol-lowering
medications, called statins, having positive effects on prostate
health, in addition to their benefits in reduction and control of high
blood pressure, heart disease, and stroke.
In a study presented to the American Urological Association, the Mayo Clinic recently reported the results of a 20 year study that followed 2,447 men between the ages of 40 and 79. You may find these results very surprising:
- Men who were taking statin drugs were three times less likely to develop prostate cancer than men not taking the drugs.
- The statin users were 57 percent less likely to develop an enlarged prostate.
- There was also evidence that statin use may protect men against erectile dysfunction.
Researchers said that these results were very positive regarding the urological health benefits of statins, but that it was too early to start recommending statins for urological disorders or as preventatives.
However, in a separate study presented by Duke University, which examined tumor samples of 254 men who had cancerous prostates removed, the inflammation levels of the tumors were 72 percent lower in men who had been taking statins. This led them to conclude that the statins have the additional benefit of reducing the level of inflammation in the prostate tumors, thereby slowing tumor development.
Keep your eyes peeled for further developments in the area of statins and prostate health. These studies are certainly positive news for those who are taking statins. Now, let's see what's prescribed for those who do not have a cholesterol-controlling need for statins.
Keeping you posted...